-
EP3810130
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3810130
| EP3810130 - POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.04.2024 Database last updated on 29.06.2024 | |
| Former | Request for examination was made Status updated on 26.03.2021 | ||
| Former | The international publication has been made Status updated on 03.01.2020 | Most recent event Tooltip | 19.04.2024 | Application deemed to be withdrawn | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Spectrum Pharmaceuticals, Inc. 157 Technology Drive Irvine, CA 92618 / US | For all designated states Hanmi Pharmaceutical Co., Ltd. 214 Muha-ro Paltan-myeon Hwaseong-si, Gyeonggi-do 18536 / KR | [2021/17] | Inventor(s) | 01 /
REDDY, Guru 4250 Quail Run Drive Danville, CA 94506 / US | 02 /
JANG, Sunyoung 550, Dongtangiheung-ro Hwaseong-si Gyeonggi-do 18469 / KR | 03 /
BYUN, Jooyun 550, Dongtangiheung-ro Hwaseong-si Gyeonggi-do 18469 / KR | [2021/29] |
| Former [2021/17] | 01 /
REDDY, Guru 120 Arden Irvine, CA 92620 / US | ||
| 02 /
JANG, Sunyoung 550, Dongtangiheung-ro Hwaseong-si Gyeonggi-do 18469 / KR | |||
| 03 /
BYUN, Jooyun 550, Dongtangiheung-ro Hwaseong-si Gyeonggi-do 18469 / KR | Representative(s) | Clements, Andrew Russell Niel, et al Schlich 9 St Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | [2021/17] | Application number, filing date | 19826967.2 | 25.06.2019 | [2021/17] | WO2019US38974 | Priority number, date | US201862689282P | 25.06.2018 Original published format: US 201862689282 P | US201962812656P | 01.03.2019 Original published format: US 201962812656 P | [2021/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020005934 | Date: | 02.01.2020 | Language: | EN | [2020/01] | Type: | A1 Application with search report | No.: | EP3810130 | Date: | 28.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.01.2020 takes the place of the publication of the European patent application. | [2021/17] | Search report(s) | International search report - published on: | US | 02.01.2020 | (Supplementary) European search report - dispatched on: | EP | 07.02.2022 | Classification | IPC: | A61K31/395, A61K31/436, A61K31/444, A61K31/517, C07K16/32 | [2022/10] | CPC: |
A61K31/517 (EP,IL,KR,US);
A61K39/001106 (EP,IL,KR);
A61K31/337 (EP,IL,KR,US);
A61K31/475 (EP,IL);
A61K31/513 (EP,IL,KR,US);
A61K31/537 (US);
A61K31/5545 (US);
A61K33/243 (EP,IL,KR,US);
A61K39/3955 (US);
A61K39/39558 (KR);
A61K45/06 (EP,IL);
A61K47/6803 (US);
A61K47/68033 (EP,IL,KR,US);
A61K47/6855 (KR,US);
A61K47/6863 (US);
A61P35/00 (KR,US);
C07K16/32 (EP,KR);
A61K2039/505 (KR,US);
A61K2039/54 (US);
A61K2039/545 (EP,IL,US);
A61K2300/00 (IL,KR);
| C-Set: |
A61K31/337, A61K2300/00 (EP);
A61K31/475, A61K2300/00 (EP);
A61K31/513, A61K2300/00 (EP);
A61K31/517, A61K2300/00 (EP); |
| Former IPC [2021/17] | A61K31/395, A61K31/436, A61K31/444, A61K31/517 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/17] | Title | German: | POZIOTINIBKOMBINATIONEN MIT EINEM ANTI-HER1-, HER2- ODER HER4-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON | [2021/17] | English: | POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF | [2021/17] | French: | COMBINAISONS DE POZIOTINIB AVEC UN ANTICORPS ANTI-HER1, HER2 OU HER4 ET LEURS PROCÉDÉS D'UTILISATION | [2021/17] | Entry into regional phase | 07.01.2021 | National basic fee paid | 07.01.2021 | Search fee paid | 07.01.2021 | Designation fee(s) paid | 07.01.2021 | Examination fee paid | Examination procedure | 07.01.2021 | Examination requested [2021/17] | 15.08.2022 | Amendment by applicant (claims and/or description) | 03.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/21] | 23.01.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/21] | Fees paid | Renewal fee | 07.01.2021 | Renewal fee patent year 03 | 27.06.2022 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2023 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2018094225 (UNIV TEXAS [US]); | International search | [A]US2017184595 (SIBILIA MARIA [AT]); | [X]WO2018094225 (UNIV TEXAS [US]) |